246 related articles for article (PubMed ID: 24175976)
1. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
2. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
3. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
4. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
Mizusako H; Tagami T; Hattori K; Ozeki T
J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
[TBL] [Abstract][Full Text] [Related]
5. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
6. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
7. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
[TBL] [Abstract][Full Text] [Related]
8. Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy.
Motoyama K; Onodera R; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
J Drug Target; 2014 Oct; 22(3):211-219. PubMed ID: 24219311
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
Mohammed AFA; Higashi T; Motoyama K; Ohyama A; Onodera R; Khaled KA; Sarhan HA; Hussein AK; Arima H
AAPS J; 2019 Apr; 21(4):54. PubMed ID: 30993472
[TBL] [Abstract][Full Text] [Related]
10. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
[TBL] [Abstract][Full Text] [Related]
11. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
12. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.
Anbharasi V; Cao N; Feng SS
J Biomed Mater Res A; 2010 Sep; 94(3):730-43. PubMed ID: 20225211
[TBL] [Abstract][Full Text] [Related]
14. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent.
Onodera R; Motoyama K; Okamatsu A; Higashi T; Arima H
Sci Rep; 2013; 3():1104. PubMed ID: 23346361
[TBL] [Abstract][Full Text] [Related]
15. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
16. [Development of Cyclodextrin-based Cancer Treatment].
Motoyama K
Yakugaku Zasshi; 2015; 135(11):1291-8. PubMed ID: 26521878
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
Ohyama A; Higashi T; Motoyama K; Arima H
Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
[TBL] [Abstract][Full Text] [Related]
19. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
[TBL] [Abstract][Full Text] [Related]
20. Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.
Onodera R; Motoyama K; Tanaka N; Ohyama A; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
Sci Rep; 2014 Mar; 4():4417. PubMed ID: 24646866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]